SEKISUI DIAGNOSTICS LLC 13D and 13G filings for Qualigen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-06-01 5:00 pm Purchase | 2020-05-22 | 13G | Qualigen Therapeutics, Inc. QLGN | SEKISUI DIAGNOSTICS LLC | 3,960 15.800% | 3,960 (New Position) | Filing |